BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20656547)

  • 1. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
    Moergel M; Abt E; Stockinger M; Kunkel M
    Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
    Kunkel M; Moergel M; Stockinger M; Jeong JH; Fritz G; Lehr HA; Whiteside TL
    Oral Oncol; 2007 Sep; 43(8):796-803. PubMed ID: 17207657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of p63 expression on survival in oral squamous cell carcinoma.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
    Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
    Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
    Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
    Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Chang HH; Kuo MY; Cheng SJ; Chiang CP
    Oral Oncol; 2009 Jul; 45(7):589-93. PubMed ID: 18952491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
    BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
    Nariai Y; Mishima K; Yoshimura Y; Sekine J
    Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
    Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
    Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC).
    Laimer K; Blassnig N; Spizzo G; Kloss F; Rasse M; Obrist P; Schäfer G; Perathoner A; Margreiter R; Amberger A
    Oral Oncol; 2009 Feb; 45(2):127-34. PubMed ID: 18620895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.